Pretreatment with standard ‐dose intravenous methylprednisolone does not improve outcomes in newly diagnosed immune thrombocytopenia (ITP)

ConclusionsInitiating methylprednisolone at a conventional dose provided no significant benefit compared to giving oral prednisone only to adults with ITP.

Source: European Journal of Haematology - March 12, 2018 Category: Hematology Authors: Ana ïs Essilini, Thibault Comont, Johanne Germain, Natacha Brun, Claire Dingremont, Brice Castel, Sophie Arista, Serge Madaule, Laurent Sailler, Maryse Lapeyre‐Mestre, Odile Beyne‐Rauzy, Bertrand Godeau, Daniel Adoue, Guillaume Moulis, Tags: ORIGINAL ARTICLE Source Type: research